פריוויג'ן

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

IMMUNOGLOBULINS, NORMAL HUMAN

Pieejams no:

CSL BEHRING LTD., ISRAEL

ATĶ kods:

J06BA02

Zāļu forma:

תמיסה לאינפוזיה

Kompozīcija:

IMMUNOGLOBULINS, NORMAL HUMAN 100 G/L

Ievadīšanas:

תוך-ורידי

Receptes veids:

מרשם נדרש

Ražojis:

CSL BEHRING AG, SWITZERLAND

Ārstniecības grupa:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Ārstniecības joma:

IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM.

Ārstēšanas norādes:

1. Replacement therapy in- Primary immunodeficiency syndromes such as:- Congenital agammaglobulinaemia and hypogammaglobulinaemia- Common variable immunodeficiency- Severe combined immunodeficiency- Wiskott-Aldrich syndrome- Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections-Children with congenital AIDS and recurrent infections2. Immunomodulation- Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count-Guillain-Barr? syndrome- Kawasaki disease3. Allogeneic bone marrow transplantation

Autorizācija datums:

2016-06-30